BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 35031226)

  • 21. The clinicopathological characteristics of muscle-invasive bladder recurrence in upper tract urothelial carcinoma.
    Shigeta K; Matsumoto K; Ogihara K; Murakami T; Anno T; Umeda K; Izawa M; Baba Y; Sanjo T; Shojo K; Tanaka N; Takeda T; Kosaka T; Mizuno R; Mikami S; Kikuchi E; Oya M
    Cancer Sci; 2021 Mar; 112(3):1084-1094. PubMed ID: 33368857
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of neoadjuvant and adjuvant chemotherapy for localized and locally advanced upper tract urothelial carcinoma: a systematic review and meta-analysis.
    Quhal F; Mori K; Sari Motlagh R; Laukhtina E; Pradere B; Rouprêt M; Necchi A; Moschini M; Shariat SF
    Int J Clin Oncol; 2020 Jun; 25(6):1037-1054. PubMed ID: 32206939
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Robotic versus other nephroureterectomy techniques: a systematic review and meta-analysis of over 87,000 cases.
    Veccia A; Antonelli A; Francavilla S; Simeone C; Guruli G; Zargar H; Perdoná S; Ferro M; Carrieri G; Hampton LJ; Porpiglia F; Autorino R
    World J Urol; 2020 Apr; 38(4):845-852. PubMed ID: 31773242
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Robot-assisted versus laparoscopic nephroureterectomy for upper-tract urothelial cancer: A population-based assessment of costs and perioperative outcomes.
    Trudeau V; Gandaglia G; Shiffmann J; Popa I; Shariat SF; Montorsi F; Perrotte P; Trinh QD; Karakiewicz PI; Sun M
    Can Urol Assoc J; 2014 Sep; 8(9-10):E695-701. PubMed ID: 25408809
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Perioperative, renal function and oncological outcomes of robot-assisted radical nephroureterectomy for patients with upper tract urothelial carcinoma.
    Gabriel PE; Pinar U; Lenfant L; Parra J; Vaessen C; Mozer P; Chartier-Kastler E; Rouprêt M; Seisen T
    World J Urol; 2023 Nov; 41(11):3001-3007. PubMed ID: 37676283
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does neoadjuvant chemotherapy have therapeutic benefit for node-positive upper tract urothelial carcinoma? Results of a multi-center cohort study.
    Shigeta K; Matsumoto K; Ogihara K; Murakami T; Anno T; Umeda K; Izawa M; Baba Y; Sanjo T; Shojo K; Tanaka N; Takeda T; Morita S; Kosaka T; Mizuno R; Arita Y; Akita H; Jinzaki M; Kikuchi E; Oya M
    Urol Oncol; 2022 Mar; 40(3):105.e19-105.e26. PubMed ID: 34454822
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Robot-assisted vs. laparoscopic nephroureterectomy for upper urinary tract urothelial carcinoma: a systematic review and meta-analysis based on comparative studies.
    Ji R; He Z; Fang S; Yang W; Wei M; Dong J; Xu W; Ji Z
    Front Oncol; 2022; 12():964256. PubMed ID: 35992849
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Robotic nephroureterectomy in the management of upper tract urothelial cancer: inching toward standard of care?
    Saini S; Pathak RA; Hemal AK
    Int Urol Nephrol; 2022 Aug; 54(8):1777-1785. PubMed ID: 35610528
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oncologic Surveillance After Radical Nephroureterectomy for High-risk Upper Tract Urothelial Carcinoma.
    Martini A; Lonati C; Nocera L; Fallara G; Raggi D; Herout R; Zamboni S; Ploussard G; Predere B; Mattei A; Simeone C; Krajewski W; Simone G; Soria F; Gontero P; Roupret M; Montorsi F; Briganti A; Shariat SF; Necchi A; Moschini M
    Eur Urol Oncol; 2022 Aug; 5(4):451-459. PubMed ID: 35504834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of contralateral kidney volume on renal function after radical nephroureterectomy: Implications for eligibility for neoadjuvant chemotherapy for upper tract urothelial cancer.
    Song W; Sung HH; Han DH; Jeong BC; Seo SI; Jeon SS; Lee HM; Choi HY; Jeon HG
    Urol Oncol; 2017 Mar; 35(3):114.e1-114.e7. PubMed ID: 27908680
    [TBL] [Abstract][Full Text] [Related]  

  • 31. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update.
    Rouprêt M; Babjuk M; Compérat E; Zigeuner R; Sylvester RJ; Burger M; Cowan NC; Böhle A; Van Rhijn BW; Kaasinen E; Palou J; Shariat SF
    Eur Urol; 2015 Nov; 68(5):868-79. PubMed ID: 26188393
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative effectiveness of neoadjuvant chemotherapy in bladder and upper urinary tract urothelial carcinoma.
    D'Andrea D; Matin S; Black PC; Petros FG; Zargar H; Dinney CP; Cookson MS; Kassouf W; Dall'Era MA; McGrath JS; Wright JL; Thorpe AC; Morgan TM; Holzbeierlein JM; Bivalacqua TJ; Sridhar SS; North S; Barocas DA; Lotan Y; Stephenson AJ; van Rhijn BW; Spiess PE; Daneshmand S; Shariat SF
    BJU Int; 2021 May; 127(5):528-537. PubMed ID: 32981193
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of Perioperative Outcomes and Complications of Laparoscopic and Robotic Nephroureterectomy Approaches in Patients with Upper-Tract Urothelial Carcinoma.
    Peng L; Mehmud I; Meng C; Tang D; Li K; Gan L; Li J; Yi F; Li Y
    Ann Surg Oncol; 2023 Jun; 30(6):3805-3816. PubMed ID: 36879036
    [TBL] [Abstract][Full Text] [Related]  

  • 34. National trends in clinical and pathologic staging for upper tract urothelial carcinoma: Implications for neoadjuvant chemotherapy.
    Rodrigues Pessoa R; Morrison JC; Konety B; Gershman B; Maroni P; Kukreja JB; Cost N; Flaig T; Kessler E; Sharma P; Kim SP
    Urol Oncol; 2021 Dec; 39(12):832.e9-832.e15. PubMed ID: 33820697
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of perioperative outcomes between open and minimally invasive nephroureterectomy: A population-based analysis.
    Nazzani S; Bazinet A; Preisser F; Mazzone E; Tian Z; Mistretta FA; Shariat SF; Saad F; Zorn KC; Montanari E; Briganti A; Carmignani L; Karakiewicz PI
    Int J Urol; 2019 Apr; 26(4):487-492. PubMed ID: 30756440
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Robot-assisted nephroureterectomy for upper tract urothelial carcinoma: results from three high-volume robotic surgery institutions.
    De Groote R; Decaestecker K; Larcher A; Buelens S; De Bleser E; D'Hondt F; Schatteman P; Lumen N; Montorsi F; Mottrie A; De Naeyer G;
    J Robot Surg; 2020 Feb; 14(1):211-219. PubMed ID: 31041588
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Perioperative outcomes of laparoscopic radical nephroureterectomy and regional lymphadenectomy in patients with upper urinary tract urothelial carcinoma after neoadjuvant chemotherapy.
    Rajput MZ; Kamat AM; Clavell-Hernandez J; Siefker-Radtke AO; Grossman HB; Dinney CP; Matin SF
    Urology; 2011 Jul; 78(1):61-7. PubMed ID: 21354598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of the Distal Ureter During Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Comprehensive Review of Literature.
    Morriss S; Zargar H; Dias BH
    Urol J; 2021 Nov; 18(6):585-599. PubMed ID: 34746998
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Impact of Venous Thromboembolism on Upper Tract Urothelial Carcinomas Undergoing Open or Minimally Invasive Radical Nephroureterectomy in the USA: Perioperative Outcomes and Health Care Costs from Insurance Claims Data.
    Tresh AS; Del Giudice F; Li S; Basran S; Belladelli F; De Berardinis E; Asero V; Ferro M; Tataru S; Maria Busetto G; Falagario U; Autorino R; Crocetto F; Barone B; Pradere B; Moschini M; Mari A; Krajewski W; Nowak Ł; Małkiewicz B; Szydełko T; Crivellaro S; Rane A; Challacombe B; Nair R; Chung BI
    Eur Urol Focus; 2024 Mar; ():. PubMed ID: 38433067
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oncological Efficacy of Robotic Nephroureterectomy vs. Open and Laparoscopic Nephroureterectomy for Suspected Non-Metastatic UTUC-A Systematic Review and Meta-Analysis.
    Rajan K; Khalifa A; Geraghty R; Parmar K; KandaSwamy G; Gómez Rivas J; Somani B; Rai BP
    Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.